Dutros 0.5 Tablet
Prescription Required
Product introduction
Dutros 0.5 Tablet is used in the treatment of benign prostatic hyperplasia. It shrinks the size of the enlarged prostate gland to relieve symptoms like pain and difficulty in passing urine.
Dutros 0.5 Tablet is used to treat enlarged prostate gland in men
Dutros 0.5 Tablet is used to treat enlarged prostate gland in men
Uses of Dutros Tablet
Benefits of Dutros Tablet
In Benign prostatic hyperplasia
When your prostate gland becomes enlarged it can cause urinary problems such as difficulty passing urine and the need to go to the toilet frequently or urgently. It can also cause urine flow to be slower. If not treated, there is a risk that your urine flow will be completely blocked. Dutros 0.5 Tablet works by relaxing muscles in the bladder and prostate. So, it can rapidly relieve the symptoms and make it easier for you to urinate. It also helps to treat uncontrollable contractions (spasms) of the bladder muscles that causes frequent urination, urgent need to urinate, and inability to control passing of urine. It also relieves painful, or frequent urination and reduces urgency to urinate. Take this medicine exactly as prescribed for maximum benefits.
Side effects of Dutros Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youβre worried about them
Common side effects of Dutros
- Decreased sperm count
- Impotence
- Decreased libido
- Ejaculation disorder
- Breast enlargement in male
- Breast tenderness in male
How to use Dutros Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Dutros 0.5 Tablet may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Dutros 0.5 Tablet. Please consult your doctor.
Pregnancy
UNSAFE
Dutros 0.5 Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Breast feeding
UNSAFE
Dutros 0.5 Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
$med_name is not indicated for use in women.
$med_name is not indicated for use in women.
Driving
SAFE
Dutros 0.5 Tablet does not usually affect your ability to drive.
Kidney
SAFE IF PRESCRIBED
Dutros 0.5 Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Dutros 0.5 Tablet may not be needed in these patients. Please consult your doctor.
Liver
CAUTION
Dutros 0.5 Tablet should be used with caution in patients with liver disease. Dose adjustment of Dutros 0.5 Tablet may be needed. Please consult your doctor.
Use of Dutros 0.5 Tablet is not recommended in patients with severe liver disease.
Use of Dutros 0.5 Tablet is not recommended in patients with severe liver disease.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Dutros 0.5 Tablet
βΉ16.7/Tablet
Dutacet 0.5mg Tablet
Kivi Labs Ltd
βΉ9.9/tablet
36% cheaper
Veltride Tablet
Intas Pharmaceuticals Ltd
βΉ20.8/tablet
35% costlier
Dutaone Tablet
Rivan Pharma
βΉ10.6/tablet
31% cheaper
Dute 0.5mg Tablet
Tetramed Biotek Pvt Ltd
βΉ12.5/tablet
19% cheaper
Dutamax Tablet
Galcare Pharmaceutical Pvt Ltd
βΉ11/tablet
29% cheaper
Quick tips
- Your doctor has prescribed Dutros 0.5 Tablet to shrink the enlarged prostate and reduce the risk of urinary retention.
- It may take 3 to 6 months to see the full beneficial effect of Dutros 0.5 Tablet. Hence, continue taking the medicine as advised by your doctor.
- Dutros 0.5 Tablet is usually well tolerated. However, it may produce some mild sexual side effects such as low sexual drive.
- Do not donate blood for 6 months after taking the last dose of Dutros 0.5 Tablet.
Fact Box
Chemical Class
Androgen Derivative
Habit Forming
No
Therapeutic Class
UROLOGY
Action Class
5 alpha- reductase inhibitor (5ARI)
Patient concerns
Related ayurvedic ingredients
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Chrousos GP. The Gonadal Hormones & Inhibitors. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 723.
- Dutasteride. Research Triangle Park, North Carolina: GlaxoSmithKline; 2001 [revised Jun. 2008]. [Accessed 04 Apr. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 04 Apr. 2019] (online) Available from:
- Dutasteride [Product Monograph]. Mississauga, Ontario: GlaxoSmithKline Inc.; 2013. [Accessed 20 June 2023]. (online) Available from:
Marketer details
Name: Demorbus India Pvt Ltd
Address: The Chambers 2nd Floor, S.G. Highway, Bodakdev, Ahmedabad, 380054, India
Country of origin: India
Lab tests offered by us
Related/Popular tests
64 people viewed this recentlyMRP
βΉ167
Inclusive of all taxes
10.0 tablets in 1 strip
SOLD OUT